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Background: YB-1 is a multifunctional protein that affects transcription, splicing, and translation.
Results: Np63, the main p63 protein isoform, interacts with YB-1 and affects YB-1 subcellular localization and regulation of
cell survival and motility genes.
Conclusion: Np63 and YB-1 interaction inhibits epithelial to mesenchymal transition and tumor cell motility.
Significance: This is the first demonstration of a physical and functional interaction between YB-1 and Np63 oncoproteins.
TheY-box binding protein 1 (YB-1) belongs to the cold-shock
domain protein superfamily, one of themost evolutionarily con-
served nucleic acid-binding proteins currently known. YB-1
performs a wide variety of cellular functions, including tran-
scriptional and translational regulation, DNA repair, drug
resistance, and stress responses to extracellular signals. Inas-
much as the level of YB-1 drastically increases in tumor cells,
this protein is considered to be one of themost indicativemark-
ers of malignant tumors. Here, we present evidence that
Np63, the predominant p63 protein isoform in squamous
epithelia and YB-1, can physically interact. Into the nucleus,
Np63 and YB-1 cooperate in PI3KCA gene promoter activa-
tion. Moreover, Np63 promotes YB-1 nuclear accumulation
thereby reducing the amount of YB-1 bound to its target tran-
scripts such as that encoding the SNAIL1 protein. Accordingly,
Np63 enforced expressionwas associatedwith a reduction of
the level of SNAIL1, a potent inducer of epithelial to mesenchy-
mal transition. Furthermore, Np63 depletion causes morpho-
logical change and enhanced formation of actin stress fibers in
squamous cancer cells. Mechanistic studies indicate thatNp63
affects cell movement and can reverse the increase of cell motility
induced by YB-1 overexpression. These data thus suggest that
Np63 provides inhibitory signals for cell motility. Deficiency of
Np63 gene expression promotes cell mobilization, at least par-
tially, through a YB-1-dependentmechanism.
The Y-box binding protein 1 (YB-1), also known as NSEP1,
CSBD, and MDR-NF1, is a member of the highly conserved
Y-box family of proteins that regulate gene transcription by
binding to the TAACC element (the Y-box) contained within
many eukaryotic promoters (1). Transcriptional targets of YB-1
include genes associated with cell death, cell proliferation, and
multidrug resistance (1, 2). YB-1 protein can also regulate gene
transcription by binding to other transcription factors such as
p53, AP1, and SMAD3 (2).
YB-1 is an important marker of tumorigenesis and is overex-
pressed in many malignant tissues, including breast cancer,
non-small cell lung carcinoma, ovarian adenocarcinoma,
human osteosarcomas, colorectal carcinomas, and malignant
melanomas (1). Mostly cytosolic, YB-1 protein shuttles
between the nucleus and cytoplasm. Cytoplasmic YB-1 acts as a
translation factor of oncogenic/pro-metastatic genes (3). It
binds to the mRNA cap structure and displaces the eukaryotic
translation initiation factors eIF4E and eIF4G, thereby causing
mRNA translational silencing (4). However, cytoplasmic YB-1
activates cap-independent translation of mRNA encoding
SNAIL1, a transcription factor that promotes epithelial-mesen-
chymal transition by suppressing E-cadherin (5). According to
those observations, the YB-1 protein level, in breast carcinoma,
is positively correlated to the increase of SNAIL1 protein level
and reduced expression of E-cadherin (6).
In normal conditions, YB-1 is located in the cytoplasm and
transiently translocates to the nucleus at the G1/S transition of
the cell cycle (7). Moreover, nuclear translocation of YB-1 was
shown to occur in response to DNA-damaging agents, phos-
phorylation at Ser-102 by AKT kinase, UV irradiation, TGF
stimulation, virus infection, hypothermia, and pharmacological
compounds (1, 8, 9). Under stress stimuli, YB-1 nuclear trans-
location requires a physical interaction with wild type p53 (10).
Herein, we report that YB-1 directly interacts with Np63
and accumulates in the nuclear compartment. Np63 is
encoded by the TP63 locus, a homologue of the p53 tumor
suppressor gene and themost ancientmember of the p53 family
(11). Because of the presence of two promoters, the TP63 gene
encodes twomajor classes of proteins as follows: those contain-
ing a transactivating domain homologous to the one present in
p53 (i.e. TAp63), and those lacking it (i.e. Np63) (12). In addi-
tion, alternate splicing at theC terminus generates at least three
p63 variants (, , and ) in each class. The TAp63 isoform
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resembles most p53, whereas the -isoforms include a con-
served protein-protein interaction domain named the sterile 
motif.
Gene knock-out mice demonstrated that p63 plays a critical
role in the morphogenesis of organs/tissues developed by epi-
thelial-mesenchymal interactions such as the epidermis, teeth,
hair, and glands (13). In adults, Np63 expression occurs in
the basal cells of stratified epithelia. High expression of
Np63 is associated with the proliferative potential of epithe-
lial cells (14) and is enhanced at the early stages of squamous
cell carcinomas (SCCs)2 (15). Down-regulation of Np63 by
SNAIL transcription factor instead was found to reduce cell-
cell adhesion and increase the migratory properties of squa-
mous carcinoma cells (16).Moreover, a partial or complete loss
of Np63 expression was associated with tumor metastasis
supporting the idea thatNp63 plays a relevant role inmetas-
tasis suppression (17, 18). Here, we provide experimental evi-
dence that the YB-1 protein associates with Np63 and such
interaction plays a critical role in the control of genes involved
in cell survival and motility.
EXPERIMENTAL PROCEDURES
Plasmids—cDNAs encoding human FLAG-tagged YB-1
were provided byDr. SandraDunn (Research Institute for Chil-
dren’s and Women’s Health, Vancouver, British Columbia,
Canada). PIK3CA promoter luciferase plasmid was provided by
Dr. Arezoo Astanehe (Research Institute for Children’s and
Women’s Health, Vancouver, British Columbia, Canada).
cDNA encoding human Np63 and Np63were previously
described (19). For bacterial expression, Np63 and Np63
cDNAs were inserted in pRSETA vector in XhoI/ClaI and
XhoI/XbaI (filled) sites, respectively. GFP and YB-1-GFP vec-
tors were provided by Dr. Paul R. Mertens (University Hospital
Aachen, Germany). PET-YB-1 was fromDr. Jill Gershan (Med-
ical College of Wisconsin, Milwaukee, WI).
Cell Lines, Transfection, and Antibodies—Squamous carci-
noma cells (SCC011 and SCC022) were described previously
and provided to us by Dr. C. Missero (20).
These cell lines were maintained in RPMI medium supple-
mented with 10% fetal bovine serum at 37 °C and 5% CO2.
A431, H1299, and MDA-MB-231 cells were obtained from
ATCC andmaintained in DMEM supplemented with 10% fetal
bovine serum at 37 °C and 5% CO2. Dox-inducible Tet-On
H1299/Np63 cells were described previously (21).
Lipofections were performed with Lipofectamine (Invitro-
gen), according to the manufacturer’s recommendations. YB-1
transient silencing was carried out with ON-TARGET plus
SMART pool YB-1-siRNA (Dharmacon) and RNAiMAX rea-
gent (Invitrogen). Np63 transient silencing in SCC011 cells
was carried out with RIBOXX (IBONI p63-siRNA pool) and
RNAiMAX reagent (Invitrogen), according to the manufactur-
er’s recommendation. An si-RNA against luciferase (si-Luc)
was used as a negative control. Anti-p63 (4A4) and anti-
actin(1–19)were fromSantaCruzBiotechnology Inc., and anti-
FLAG M2 was from Sigma. PARP, AKT, pAKT (Ser-473) and
rabbit polyclonal YB-1 antibody (Ab12148) were fromCell Sig-
naling Technology (Beverly, MA). Mouse monoclonal E-cad-
herin (ab1416) and SNAIL1 antibodies were from Abcam
(Cambridge, UK). Mouse monoclonal N-cadherin (610921)
was from BDTransduction Laboratories. Cy3-conjugated anti-
mouse IgG and Cy5-conjugated anti-rabbit IgG were from
Jackson ImmunoResearch. Doxycycline was from Clontech.
Chromatin Immunoprecipitation (ChIP) Assay—ChIP was
performed with chromatin from human MDA-MB-231 cells
transfected with Np63, Np63, and/or FLAG YB-1, as
described previously (22). Real time PCR was performed with
the 7500 Applied Biosystems apparatus and SYBR Green Mas-
terMix (Applied Biosystems) using the following oligonucleo-
tides: PIK3CA-For, CCCCCGAACTAATCTCGTTT, and
PIK3CA-Rev, TGAGGGTGTTGTGTCATCCT.
Sequential ChIP was performed with chromatin from
SCC011 cells. Method of chromatin extraction and controls
used were previously described (22).
Chromatin sampleswere subjected to pre-clearingwith 80l
of salmon spermDNA-saturated agarose A beads for 2 h at 4 °C
with rotation. The first immunoprecipitation stepwas obtained
with p63 antibodies (4A4). After several washes, the immuno-
complexes were extracted from beads with 100 l of 2%
TE/SDS. The second immunoprecipitation step was obtained
with YB-1 (Ab12148) antibodies after a 30-fold dilution in DB
buffer (50mMTris-HCl, 5mM EDTA, 200mMNaCl, 0.5%Non-
idet P-40, 15 mM DTT). Samples were incubated overnight at
4 °C with rotation. Immunocomplexes were extracted from
beads as described above. Immunoprecipitated protein-DNA
complexes were subjected to reverse cross-linking and protein-
ase K treatment. DNA was purified by phenol/chloroform
extraction and resuspended in 40 l of TE. 2 l were used for
PCR performed with the following primers: PIK3CA promoter
For, ACAAACCCCTGGAATGTGAG, and PI3KCA promoter
Rev, TGGAAAAGCGTAGGAGCAGT.
Immunoblot Analyses and Co-immunoprecipitation—Im-
munoblots and co-immunoprecipitations were performed as
described previously (19). To detect p63/YB-1 interaction in
SCC011 cells, 5.0 105 cells were plated in 60-mm dishes. For
co-immunoprecipitations, whole cell extracts, precleared with
30l of proteinA-agarose (50% slurry; RocheApplied Science),
were incubated overnight at 4 °C with anti-YB-1(3 g) or
-rabbit IgG (3 g). The reciprocal experiment was performed
with anti-p63 (2 g) or -mouse IgG.
Far Western Assays—Far Western assays were conducted
according to the protocol described by Cui et al. (23). Increas-
ing amounts (0.2, 0.5, and 1.5 g) of Np63 or Np63
recombinant proteins were subjected to SDS-PAGE and trans-
ferred to PVDF membrane (IPVH00010 Immobilon Millipore,
Milan, Italy). Bovine serum albumin (0.5 and 1.5 g; BSA) was
used as control of unspecific binding and equal loading of BSA,
and recombinant YB-1 or p63 proteins in far Western blotting
was verified by Coomassie staining (data not shown).
Luciferase Reporter Assay—MDA-MB-231 cells were
co-transfected with Np63, PIK3CA luc promoter, and pRL-
TK. YB-1 gene silencing was carried out 24 h before plasmid
2 The abbreviations used are: SCC, squamous cell carcinoma; For, forward;
Rev, reverse; PARP, poly(ADP-ribose) polymerase; Dox, doxycycline; TRITC,
tetramethylrhodamine isothiocyanate; S, speed; P, persistence time; Ab,
antibody; HPRT, hypoxanthine-guanine phosphoribosyltransferase.
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transfection. At 24 h after transfection, cells were harvested in
1 PLB buffer (Promega), and luciferase activity was measured
using the Dual-Luciferase Reporter system (Promega) using
pRL-TK activity as internal control. Firefly-derived luciferase
activity was normalized for transfection efficiency. Successful
transfection of p63 and silencing of YB-1 was confirmed by
immunoblotting.
RNA Immunoprecipitation—1  106 MDA-MB-231 cells
were seeded in 100-mm plates and transfected with pcDNA3.1
or Np63 expression plasmids. 24 h after transfection, cells
were fixed with 1% formaldehyde for 10 min and washed twice
in ice-cold PBS. Cell extracts were prepared in RNA immuno-
precipitation buffer (0.1% SDS, 1% Triton, 1 mM EDTA, 10 mM
Tris, pH 7.5, 0.5 mM EGTA, 150 mM NaCl) supplemented with
complete protease inhibitor mixture (Sigma), and sonication
was carried out with BANDELINE SONOPULSE HD2200
instrument under the following conditions: 8 pulses of 4 s at
0.250% of intensity. Cell extracts were incubated with anti-
YB-1 (3 g) at 4 °C overnight. The RNA-protein immunocom-
plexes were precipitated with protein A beads (Roche Applied
Science) saturatedwith tRNA and, after reverse cross-link, sub-
jected to real time PCR.
Semi-quantitative and Real Time PCR—For PCR analysis,
total RNA was isolated using the RNA mini extraction kit
(Qiagen, GmbH, Hilden, Germany) according to the manufac-
turer’s instructions. Total RNA (1 g) was used to generate
reverse-transcribed cDNA using SuperScript III (Invitrogen).
PCR analysis was performed with the following primers: Twist
(For), 5-AGAAGTCTGCGGGCTGTG, and Twist (Rev), -
TCTGCAGCTCCTCGTAAGACT; YB (For), 5-CGCAGTG-
TAGGAGATGGAGAG, and YB (Rev), 5-GAACACCACCA-
GGACCTGTAA; and HPRT (For), 5-CCT GCT GGA TTA
CAT TAA AGC, and HPRT (Rev), 5 CTT CGT GGG GTC
CTT TTC.
SNAIL1 amplification was performed using Quantitect
Primers/Hs SNAIL1 from Qiagen (GmbH, Hilden, Germany).
The amplification sequence consisted of 30 cycles of 94 °C for 1
min, 55 °C for 1min, and 72 °C for 1 min. PCR products were
resolved by 2% agarose electrophoresis. RT-PCR amplification
results were analyzed byQuantityOne software (Bio-Rad). Real
time PCR was performed with a 7500 RT-PCR Thermo Cycler
(Applied Biosystem) as already described (22). HPRT was used
for normalization. The results were expressed with the value
relative to HPRT (set at 1) for each mRNA sample.
Immunofluorescence—A431, SCC011, and SCC022 cells
(2.5  105) were plated in 35-mm dishes and grown on micro
cover glasses (BDH). 24 h after seeding, cells were washed with
cold phosphate-buffered saline (PBS) and fixed with 4% para-
FIGURE 1. Np63 and YB-1 are co-expressed in squamous carcinoma cell lines. a, whole cell lysates were obtained from H1299 (non-small cell lung
carcinoma), A431 (epidermoid carcinoma cell line), and SCC011 and SCC022 (keratinocyte-derived SCC) cells. 30g of total protein extractswere separated by
SDS-PAGE and subjected to immunoblot (IB). Proteins were detected with specific antibodies as indicated. Images were acquired with CHEMIDOC (Bio-Rad)
and analyzedwith the Quantity-ONE software. b,A431, SCC011, and SCC022 cells were seeded (2.5 105) on a 35-mmdish and grown onmicro cover glasses
(BDH). After 24 h at seeding, cells were fixed and subjected to double immunofluorescence using rabbit primary YB-1 antibody and Fitch-conjugated
secondary antibodies (green). p63 proteinwas detected usingmouse anti-p63 andCy3-conjugated secondary antibodies (red). Images ofmerge (yellow) show
the co-expression of two proteins.
FIGURE 2. Np63 interacts with YB-1. a, extracts from SCC011 cells were
immunoprecipitated (IP) with anti-YB-1 antibodies, and the immunocom-
plexes were blotted and probed with anti-p63 as indicated. b, extracts from
SCC011 cells were immunoprecipitated with anti-p63 antibodies, and the
immunocomplexeswereblottedandprobedwith anti-YB-1. Sampleswithno
antibody (no Ab) or irrelevant -mouse and -rabbit antibodies were
included as controls. IB, immunoblot.
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formaldehyde (Sigma) for 15 min at 4 °C. Cells were permeabi-
lized with ice-cold 0.1% Triton X-100 for 10 min and then
washedwith PBS. p63was detected using a 1:200 dilution of the
monoclonal antibody 4A4.
YB-1 was detected using 1:100 dilution of the YB-1 antibody
(Ab12148). After extensive washing in PBS, the samples were
incubated with Cy3-conjugated anti-mouse IgGs and Cy5-con-
jugated anti-rabbit IgGs at room temperature for 30 min. After
PBS washing, the cells were incubated with 10 mg/ml 4,6-
diamidino-2-phenylindole (DAPI) (Sigma) for 3 min. The
glasses were mounted with Moviol (Sigma) and examined
under a fluorescencemicroscope (Nikon). Imageswere digitally
acquired and processed using Adobe Photoshop software CS.
H1299 and MDA-MB-231 cells (5.0  105) were plated in
35-mmdishes, grown onmicro cover glasses (BDH), and trans-
fectedwith 0.2g of pcDNAYB-1/GFPplasmidwith orwithout
0.6 g of Np63 or Np63 plasmid. The GFP empty vector
was used as control (data not shown). 24 h after transfection,
cells were subjected to the immunofluorescence protocol as
described above.
Cytoskeleton Analysis—Actin bundles were stained with
TRITC-conjugated phalloidin. Cell fixation was performed with
4% paraformaldehyde for 20 min and then permeabilized with
0.1% Triton X-100 (Sigma) in PBS one time for 10 min. Actin
staining was done by incubating sample with TRITC-phalloidin
(Sigma) inPBS for 30min at roomtemperature. Images of fluores-
cent cells were collected with a fluorescent inverted microscope
(IX81,Olympus,Tokyo, Japan)equippedwithanORCA2.8digital
camera (Hamamatsu Photonics, Japan).
Time-lapse Microscopy—SCC011 cells were cultured on
35-mm dishes (Corning, NY) at 2  104 cells/dish density.
Np63 transient silencing was performed as described under
“Experimental Procedures.” At 48 h from the addition of
Np63 si-RNA, the culture dishes were placed in a mini-in-
cubator connected to an automated stage of an optical micro-
scope (Olympus Co., Japan). Images of selected positions of the
cell culture were collected in bright field every 10 min for 12 h.
The bright field images were mounted to obtain 72-frame time
lapse video for each position. Cell trajectories were recon-
structed from time lapse video using Metamorph software
(Molecular Device, CA). Root mean square speed (S) and per-
sistence time (P) were chosen as relevant parameters to
describe the macroscopic features of cell migration in the dif-
ferent experimental conditions. These parameters were calcu-
lated according to the procedure reported byDunn (24). Briefly,
mean-squared displacement of each cell was calculated accord-
ing to overlapping time interval methods (25). Subsequently, S
and P were estimated by fitting the experimental data of the
mean-squared displacement to a linear approximation of the
persistent random walk model. The upper limit for the data
fitting was set at approximately 200min for each cell because of
the deviation from linearity that was observed at higher time
points. The fitting procedure provided (S, P) pairs for each cell
and the statistical significance between S and P values of the
different experimental setups was assessed by performing a
nonparametric Kruskal-Wallis test in Matlab (MathWorks,
MA). p values 0.05 were considered significant.
Cell migration in H1299 cells was evaluated with a similar
approach. Briefly, cells were cultured on 35-mm dishes (Corn-
ing, NY) at a density of 2 104 cells/dish. Np63 expression
was inducedwith 2g/ml doxycycline for 48 h. 16 h after trans-
fection, cell dishes were placed in a mini-incubator connected
to an automated stage of an optical microscope (Cell[caret]R,
Olympus Co., Japan). Time 0 images of selected position were
collected in fluorescence to localize transfected cells. Then, at
the same positions, images were recorded in bright field every 10
min for 12 h. Data analysis was performed as described above.
RESULTS
YB-1 Interacts withNp63 in Vitro and inVivo—As a result
of a comprehensive screening for Np63 interactors, using
affinity purification followed by mass spectrometry, we identi-
fied a set of proteinswithDNA/RNAbinding activity, including
YB-1 (26). We decided to confirm the interaction between
Np63 and YB-1 in SCC as in this cellular context the TP63
gene is often amplified and/or overexpressed (27). Immunob-
lots and immunofluorescence assays performed in A431,
SCC022, and SCC011 cell lines showed intense signals for both
proteins thus confirming that endogenous YB-1 and Np63
are abundantly co-expressed in human squamous carcinoma
cells (Fig. 1, a and b).
We next performed co-immunoprecipitation experiments in
SCC011 cells. Immunocomplexes containing Np63 and
FIGURE 3. Np63 but not Np63 interacts with YB-1. a, H1299 cells
were transiently transfectedwith5gofNp63 (left panel) orNp63 (right
panel) expression vectors. Equal amounts (1 mg) of extracts were immuno-
precipitated (IP) with anti-p63 antibodies (4A4) or unrelated -mouse IgG.
The immunocomplexeswereblotted andprobedwith anti-p63 andanti-YB-1
antibodies, as indicated. b, far Western analysis. Increasing amounts of puri-
fied recombinantNp63 (0.2, 0.5, and 1.5),Np63 (0.2, 0.5, and 1.5), or BSA
(0.5 and 1.5) were subjected to SDS-PAGE. After Coomassie staining to mon-
itor equal loading, the proteins were transferred to a PVDF membrane, and
the filter was incubated with purified YB-1 recombinant protein (0.8 g/ml).
After extensive washing, the membrane was subjected to immunoblotting
(IB) with YB-1 antibodies followed by ECL detection. Recombinant YB-1 pro-
tein (0.1 g) was used as positive control.m.w.,molecular weight markers.
Np63 Interacts with andModulates YB-1 Functions
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YB-1 were isolated from total cell lysates, using either antibod-
ies against YB-1 or antibodies against p63 thus confirming the
interaction inferred by mass spectrometry (Fig. 2, a and b). To
determine whether YB-1 interacts specifically with the -iso-
form of Np63, we transfected p63 null H1299 cells with
Np63 or Np63 to perform co-immunoprecipitation
assays. As shown in Fig. 3a, YB-1 associates with Np63 but
notNp63. This result was also confirmedby farWestern blot
analysis using Np63, Np63, and YB-1 recombinant pro-
teins purified by affinity chromatography (Fig. 3b). The
obtained results indicate that the -isoform C-terminal region
is involved in the association with YB-1, and the interaction
between the two proteins requires no additional factors.
Np63 Induces YB-1 Nuclear Accumulation—It has been
reported that YB-1 is ubiquitously expressed and predomi-
nantly localized to the cytoplasm (2), Np63 is mainly
expressed by basal and myoepithelial cells in skin and glands
and is almost completely restricted to the nuclear compartment
(29). Because we noticed some overlapping between the p63
and YB-1 immunofluorescence signals in the nucleus of squa-
mous carcinoma cell lines, we sought to determine whether
Np63 has an effect on YB-1 subcellular localization. Fusion
of YB-1 with the green fluorescent protein (YB-1-GFP) was
transfected in H1299 cells. H1299 cells are p63 null and express
moderate levels of endogenous YB-1. GFP-positive cells were
counted, and 95% showed a strong cytoplasmic signal, although
in the remaining 5%, the signal was nuclear or distributed
between the nucleus and cytoplasm (Fig. 4, a and b). A very
similar result was observed following Np63 co-transfection
(Fig. 4, b and c, lower panel). Remarkably, combined expression
of YB-1-GFP and Np63 caused a dramatic change of YB-1-
GFP subcellular localization. In fact, among the GFP-positive
cells, more than 40% showed an intense nuclear signal (Fig. 4, b
and c, upper panel); an additional 20% exhibited YB-1-GFP
almost equally distributed between the nucleus and cytoplasm,
and the remaining 40% exhibited exclusively cytoplasmic YB-1-
GFP (Fig. 4b). As expected, Np63 and Np63 immunoflu-
orescence signals were almost exclusively nuclear (Fig. 4c).
Np63 is a selective nuclear marker of human breast
myoepithelial cells. Np63 persists in benign lesions of the
breast, although it consistently disappears in invasive carcino-
mas (30). We transfected Np63 in MDA-MB-231 cells,
human metastatic breast carcinoma cells lacking p63 but
expressing high level of endogenous YB-1. As shown in Fig. 5, in
cells with no detectable p63 signal, YB-1 exhibited a largely
prevalent cytoplasmic localization (Fig. 5a, white arrows),
although 95% of Np63-expressing cells showed a strong
YB-1 nuclear staining (Fig. 5a, yellow arrows). We verified this
observation by nuclear/cytoplasmic fractionation of MDA-
MB-231 cells transfected with Np63 or Np63. Endoge-
nousYB-1 protein, inMDA-MB-231 cells, was detectable as 50-
and 36-kDa immunoreactive forms. Both forms of YB-1 appear
to accumulate in the nuclear compartment of cells transfected
with Np63 but not Np63 (Fig. 5b). Immunoblots with
antibodies against PARP-1 (nuclear) and AKT (cytoplasmic)
were performed to check for the quality of the fractionation.
Interestingly, although the amount of total AKT was compara-
ble, phosphorylated AKT, at serine 473, was enhanced in
Np63 but not Np63-transfected cells (Fig. 5b). This
observation was in line with previous data showing the specific
FIGURE 4.Np63 induces YB-1 nuclear accumulation. a,H1299 cells (2.3 105)were seeded at 60% confluency in 24 24-mmsterile coverglasses placed
in 60-mm dishes and transiently transfected with GFP-YB-1 expression vector (0.3 g). GFP-YB-1 was detected by direct immunofluorescence. b, H1299 cells
(2.3 105) were seeded as described in a and transiently transfected with GFB-YB-1 (0.3 g) along with 1 g of Np63 or Np63 expression vectors. Plot
shows the percentage of nuclear (dark gray), nucleo-cytoplasmic (gray), and cytoplasmic (white) GFP-YB-1 in cells transfected with Np63 or Np63
expressionvectors. Eachexperimental point is the averageof countsperformedon100 cells in five independent fields. Eachhistogrambar represents themean
and standard deviation of values from three biological replicates. c,H1299 cells (2.3 105) were transfected as described in b. GFP-YB-1was detected by direct
immunofluorescence (green), and p63was detected using anti-p63 antibodies and secondary anti-mouse Cy3-conjugated (red). DAPI was used to stain nuclei.
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ability of the Np63 isoform to promote PI3K/AKT pathway
activation (31).
We then evaluated the contribution ofNp63 to YB-1 sub-
cellular distribution in SCC011 cells expressing both proteins
endogenously. To this aim we analyzed YB-1 subcellular distri-
bution by immunoblot on nuclear/cytoplasmic fractions after
depletion of Np63 by siRNA. As shown in Fig. 6, a and b, fol-
lowing p63 knockdown the YB-1 nuclear pool was dramatically
reduced, and the36-kDa formofYB-1becamedetectable (Fig. 6a).
Np63 and YB-1 Bind to the PIK3CA Gene Promoter and
Cooperate in Its Transcriptional Activation—ThePIK3CA gene
encodes the p110 catalytic subunit of the PI3K and is a well
characterized YB-1 direct transcriptional target (32). We spec-
ulated thatNp63 should increase PIK3CA promoter activity
because of its ability to cause YB-1 nuclear accumulation. We
tested this hypothesis by luciferase assays. As shown in Fig. 7a,
Np63 transfection in MDA-MB-231 cells caused a relevant
increase of the PIK3CA promoter activity that was consistently
attenuated by YB-1 knockdown. In addition, we observed that
Np63 was able to transactivate the PIK3CA promoter in a
dose-dependent manner, although Np63 was completely
ineffective (Fig. 7b).
The role of Np63 and YB-1 in PIK3CA promoter activa-
tion was thoroughly investigated by chromatin immunopre-
cipitation (ChIP). We first performed ChIP assays in MDA-
MB-231 cells transfected with Np63 or Np63 using
anti-p63 (4A4) antibodies and PIK3CA promoter-specific
primers. As shown in Fig. 8a, Np63, but not Np63, binds
to the genomic sequence of the PIK3CA promoter.
Then we evaluated the effect of Np63 expression on the
binding of YB-1 to the PIK3CA promoter. FLAG-YB-1 was
transfected, in MB-MDA-231 cells, with or without Np63
plasmid. ChIP was carried out with anti-FLAG antibodies and
coupled with quantitative real time PCR. As show in Fig. 8b,
FLAG-YB-1 efficiently binds to the PIK3CA promoter, and its
binding was substantially increased by Np63. Finally, by
using a sequential chromatin immunoprecipitation assay (Re-
ChIP) in SCC011 cells, expressing endogenous Np63 and
YB-1, we found that both proteins are recruited to the PIK3CA
proximal promoter suggesting that they cooperate in PIK3CA
gene transactivation as a complex (Fig. 8c).
Np63 Affects YB-1 Binding to SNAIL and YB-1 mRNAs—
Cytoplasmic localization of YB-1 was associated with binding
and translational activation of SNAIL1mRNA (33). Snail1 pro-
tein is a transcriptional repressor of Np63 and E-cadherin
and promotes the epithelial-mesenchymal transition in several
epithelium-derived cancer cell lines (34).We first observed that
Np63 overexpression in MB-MDA-231 caused a reduction
of SNAIL1 protein level (Fig. 9a). Such a reduction was not
associated with a decrease of SNAIL1 mRNA levels (Fig. 9b)
thereby suggesting that the SNAIL1 protein was down-regu-
lated at the translational level. We hypothesized that the spe-
FIGURE 5. Endogenous YB-1 accumulates in the nucleus of breast cancer cells expressingNp63. a,MDA-MB-231 cells were seeded at 60% confluency
(2.3105) on2424-mmsterile coverglassesplaced in60-mmdishes and transiently transfectedwith1gofNp63expression vector. Cellswere fixedand
subjected to double indirect immunofluorescence using rabbit primary YB-1 antibody and Fitch-conjugated secondary antibodies (green). p63 protein was
detected using mouse anti-p63 and Cy3-conjugated secondary antibodies (red). DAPI was used to stain nuclei (blue). A representative image is given of a cell
expressing Np63 and showing nuclear endogenous YB-1 (yellow arrows). A representative image is given showing YB-1 cytoplasmic localization in cells
bearing no detectable Np63 expression (white arrows). b, MB-MDA-231 cells were transiently transfected with a fixed amount (5 g) of an empty vector
(mock) and Np63 or Np63 expression vector in 100-mm dishes. 24 h after transfection, cell lysates were fractionated to obtain cytoplasmic (cy) and
nuclear (nu) fractions. 20 g of nuclear and cytoplasmic extracts were separated by SDS-PAGE and subjected to immunoblot. Proteins were detected with
specific antibodies, as indicated. PARP and total AKT were used as nuclear and cytoplasmic controls, respectively, to check for cross-contamination. Images
were acquired with CHEMIDOC (Bio-Rad) and analyzed with the Quantity-ONE software.
FIGURE 6. Np63 depletion reduces the pool of nuclear YB-1. a, SCC011
cells were seeded at 60% confluency (1.5  106) in 100-mm dishes. 24 h after
seeding, cells were transiently silenced with IBONI p63-siRNA pool (20 nm final
concentration). 48 h after p63-silencing, cell lysates were fractionated to obtain
cytoplasmic (cy) and nuclear (nu) fractions. Nuclear and cytoplasmic extracts
were separated by SDS-PAGE and subjected to immunoblot. Proteins were
detectedwith specific antibodies, as indicated. PARP and total AKTwere used as
nuclear and cytoplasmic control respectively, to check for cross-contamination.
Imageswere acquiredwith CHEMIDOC (Bio-Rad) and analyzedwith the Quanti-
ty-ONE software. b,plots show thepercentage of YB-1 subcellular distribution in
control sample (upper panel) and in p63-silenced sample (lower panel) consider-
ing the total amount of YB-1 between the nucleus and cytoplasm as 100%.
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cific association of Np63 with YB-1 would reduce the
amount of YB-1 bound to the SNAIL1 transcript. To test this
hypothesis, we performed RNA-immunoprecipitation coupled
with real time PCR to quantitate the amount of SNAIL1mRNA
bound to endogenous YB-1, in mock and Np63-transfected
MDA-MB-231 cells. The obtained results confirm that
Np63 reduces the amount of YB-1 bound to SNAIL1 tran-
script (Fig. 9c). A similar analysis performed on the YB-1 tran-
script gave the same result (Fig. 9d).
Np63 Affects Cell Shape and Motility—So far, little atten-
tion has been focused on the effects of Np63 on epithelial
cancer cell morphology and motility. We have unexpectedly
noted a profound change in cell morphology when SCC011
cells were depleted of Np63 by siRNA. SCC011 cells are
FIGURE 7. Np63 and YB-1 activates the PIK3CA gene promoter. a, MB-MDA cells were transfected with 1 g of PIK3CA promoter luciferase reporter
plasmid. The luciferase activity upon siRNA-mediated knockdown of endogenous YB-1 was measured in the presence or absence of Np63 expression.
Values are shown as mean S.D. of three biological replicates. The extent of YB-1 knockdown was documented by Western blotting as shown in the lower
panel. b,MB-MDA-231 cells were seeded at 60% confluency (1.2 106) in 100-mmdishes and transiently transfected with 1g of PIK3CA promoter luciferase
reporter plasmid and the indicated amounts of Np63 or Np63 plasmid. Values are the mean S.D. of three independent experimental points. Lower
panel, immunoblotting (IB) with indicated antibodies to detect proteins in samples transfected with different amounts of Np63 or Np63.
FIGURE8.Np63 increasesYB-1binding to thePIK3CAgenepromoter.a,MDA-MB-231 cellswere seededat 60%confluency (1.2106) in 100-mmdishes
and transiently transfectedwithNp63orNp63plasmid (5g). After formaldehyde cross-linking, theDNA-proteins complexeswere immunoprecipitated
(IP) with anti-p63 (4A4) antibody. ImmunoprecipitatedDNAwas PCR-amplifiedwith PIK3CApromoter oligonucleotides and 18 S rRNAoligonucleotides (right).
Thedataobtained fromtheChIP assayweremeasuredbydensitometry andarepresentedas signal relative to the input (left).b,MDA-MB-231 cellswere seeded
at 60% confluency (1.2  106) in 100-mm dishes and transiently transfected with 3FLAG empty vector or 3FLAG-YB-1 (5 g) plasmid with or without
Np63 (2.5 g) expression vector. The cells were cross-linked with formaldehyde, and DNA-protein complexes were immunoprecipitated with anti-FLAG
antibody or irrelevant IgG antibody as negative control. The DNA immunoprecipitates were analyzed by quantitative PCR using PIK3CA or GAPDH promoter
oligonucleotides. Quantitative RT-PCR results were analyzed with the CT method and expressed as fold of enrichment with respect to the IgGAb control
samples. Values are represented as the mean of three independent experiments. c, SCC011 cells at 85% confluency were fixed with formaldehyde, and the
DNA-protein complexes were subjected to sequential ChIP with anti-p63 (4A4), anti-YB-1(Ab12148), or irrelevant IgG antibody as described under “Experi-
mental Procedures.” Immunoprecipitated DNA was PCR-amplified with PIK3CA promoter primers and 18 S rRNA primers to check the quality of the input
chromatin and the cleaning of the other samples.
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round in shape, and under high density culture conditions, they
appear orderly arranged with tight cell-cell contacts. Con-
versely, Np63-depleted cells tend to lose their contacts and
exhibited an unusual extended phenotype that was distinct
from that of the control cells cultured at the same density (Fig.
10a). The unusual change in morphology of Np63-depleted
cells indicated possible alterations in actin cytoskeleton organi-
zation. Therefore, we examined the status of actin stress fibers
at the level of individual cells, in control and Np63-depleted
cells, with TRITC-phalloidin followed by fluorescent micros-
copy. As shown in Fig. 10b, the control cells exhibited a diffuse
pattern of actin staining, although Np63-depleted cells dis-
played a more substantial enhancement of actin stress fibers sug-
gesting an inhibitory effect of Np63 on cancer cell motility.
Remarkably, compared with the control cells, Np63-depleted
SCC011 cells express higher levels of N-cadherin and lower
amounts of E-cadherin, suggesting that theywere undergoing epi-
thelial to mesenchymal trans-differentiation (Fig. 10c).
We determined the influence of Np63 on cell motility by
time-lapse microscopy using siRNA-based silencing of endog-
enous Np63 in SCC011 cells. Silencing efficiency was about
90% as determined by fluorescent staining for p63 protein (data
not shown). SCC011 migration was characterized by oscilla-
tions of the cells around their initial adhesion site. These oscil-
lations occurred at random directions in space, as reported in
the windrose plots of the trajectories (Fig. 10d, inset). Con-
versely, Np63 silenced cells display much wider oscillations
(Fig. 10d). These observationswere confirmed by the analysis of
themigration parameters “Speed (S)” and “persistence time (P)”
that are computed from cell tracks and are a measure of the
frequency of cell steps and of the minimum time that is neces-
sary for a cell to significantly change direction. According to
these parameters, SCC011 exhibit lower speeds (p 0.05) and
shorter persistence times (0.26  0.03 m/min and 6.5  0.7
min) with respect to Np63-depleted cells (0.44  0.05
m/min and 8.2  2.3 min). These data indicate a role for
Np63 in affecting cell motility. In particular, the absence of
Np63 causes the cells to migrate faster with less frequent
direction changes, which enables the cells to explore larger
areas in a fixed time interval.
To gain a better insight into the effects of the interaction of
Np63 and YB-1 on cell migration, we used the genetically
modified Tet-On-H1299 cells expressing Np63 upon Dox
addition (Fig. 11a). Cells were transfected with GFP or GFP-
FIGURE9.Np63affectsSNAIL1protein level andYB-1binding toSNAIL1andYB-1mRNAs inMDA-MB-231cells.a,MDA-MB-231cellswere transfected
with an empty vector (mock) or a fixed amount (1g in 60-mm dishes) ofNp63 orNp63 expression vector. 24 h after transfection, cells were harvested,
and total extractswereprepared. 20gof eachextractwere loadedonSDS-PAGEand subjected to immunoblotwith the indicated antibodies.b,MB-MDA-231
cells were transfected with an empty vector or Np63 encoding plasmid. 24 h after transfection, total RNA was purified and retrotranscribed as described
under “Experimental Procedures.” The expression level of Np63 was checked by immunoblot (right panel). WB, Western blot. PCR was performed with
primers designed to specifically amplify SNAIL1, TWIST, or HPRT transcripts and analyzed by agarose gel electrophoresis (left panel). Plot showing the level of
SNAIL1 and TWIST transcripts was normalized respect to HPRT. Values are the mean of three independent experiments (lower panel). Nuclear extracts from
Np63 transfected MB-MDA-231 cells were immunoprecipitated with anti-YB-1 antibody. After reverse cross-linking, the YB-1-bound RNA was purified,
retrotranscribed, and subjected to quantitative RT-PCR analysis using oligonucleotides designed to specifically amplify SNAIL1 transcript (c) or YB-1 transcript
(d). Plots represent the % of enrichment of SNAIL1/YB-1 transcript normalized as indicated under “Experimental Procedures.” 1:50 of the input extract was
loaded as control. The values are the means S.D. of three biological replicates.
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FIGURE 10. Np63 affects cell shape and motility. a, SCC011 cells were transiently silenced with IBONI p63-siRNA pool (20 nm final concentration). Cells
were fixedand subjected todouble immunofluorescence48hafter silencing, as alreadydescribed.b,proteinextracts fromcontrol andp63-depletedcellswere
separated by SDS-PAGE and subjected to immunoblot. Proteins were detected with specific antibodies. c, actin staining with TRITC-conjugated phalloidin of
control and Np63-depleted SCC011 cells (see “Experimental Procedures”). Cell expressing Np63 displayed a round morphology. Conversely, Np63-
depleted cells had a polarized morphology with more evident lamellipodia and trailing edge. d,windrose plot of trajectories described by Np63 depleted
SCC011or SCC011 control cells (inset) in 12-h time lapse video. Only 15 cell trajectorieswere reported in eachplot for graphical clarity. E-cad, E-cadherin;N-cad,
N-cadherin.
FIGURE 11. Effects ofNp63 and YB-1 on cell migration. a, after being subjected to themigration experiment, extracts from Tet-On H1299 cells, induced
(dox) or not (dox) with doxycycline, were prepared and subjected to immunoblot analysis to monitor Np63 induced expression. b, trajectories of
GFP/YB-1- or GFP (insets)-transfected cells. Inducible H1299/Np63 cells were transfectedwith a fixed amount of GFP-YB-1(1g) or GFP empty vector (1g).
4 h after transfection, 2g/ml doxycycline was added to induceNp63 expression, and 16 h later uninduced (Dox) and induced (Dox) cells were tracked
with optical microscopy. Plots represent data from the following number of cells (YB-1/dox 79; YB1/dox 69; control/dox 44; control/dox 49). c, bar
chart of speed (S; gray bars) and persistence ratios (P;white bars). The ratios are computed by dividing the population average values of speed and persistence
for H1299 control cells ( Dox) and Np63-expressing cells ( Dox).
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YB-1 plasmid, and unfluorescent and fluorescent cells were
tracked separately. Cells migrated describing trajectories that
are randomly distributed in plane, as depicted in plots of Fig.
10b. In Dox-free medium (Dox), GFP-YB-1-expressing cells
were characterized by a significantly higher S and lower P
(0.69 0.04 m/min and 8.4 0.5 min) than cells expressing
GFP alone (0.54  0.05 m/min and 15  2.1 min). Remark-
ably, in Dox-supplemented medium (Dox), GFP-YB-1-ex-
pressing cells exhibited S andP values (0.62 0.05m/min and
9.2  1.0 min), which were not significantly different from
those of cells transfected with GFP alone (0.68 0.05 m/min
and 8.6  0.9 min) (Fig. 10c). We also noticed that unfluores-
cent cells were characterized by the highest S values suggesting
that expression of the green fluorescent protein alters cell
migration to some extent (data not shown). However, S of
unfluorescent cells with or withoutDoxwas comparable. Over-
all, these data indicate that Np63 expression can revert the
increase of cell motility induced by YB-1-enforced expression.
DISCUSSION
In normal epithelium, Np63 protein expression is abun-
dant in basal cells and decreases with differentiation (35). Tran-
sient overexpression of Np63 was shown to enhance cell
proliferation, inhibit differentiation, and promote malignant
conversion of primary keratinocytes (36, 37). However,
enhanced and stable expression of Np63, as seen in human
squamous cell carcinomas, is believed to alter skin homeostasis
and be directly implicated in the etiology of human cutaneous
carcinomas. In normal cells, YB-1 is mainly detected in the
cytosol, particularly at the perinuclear region, with a minor
pool located in the nucleus (38). Nuclear localization of YB-1
appears to be critical for its role in promoting proliferation. In
fact, in the nucleus YB-1 may not only act as a transcription
factor of various genes that are closely associated with DNA
replication, cell proliferation, andmultidrug resistance but also
exert SOS signaling against genotoxic factors that could under-
mine the integrity of highly proliferative basal cells.
This report unveils a novel protein-protein association
involvingNp63 andYB-1. This specific association results in
the accumulation of nuclear YB-1, as shown by immunofluo-
rescence assays and nuclear-cytoplasmic fractionation. More-
over, we have demonstrated that Np63 and YB-1 cooperate
in PIK3CA gene activation with both being recruited to the
PIK3CA proximal promoter, thereby supporting the hypothesis
that this molecular association can function as a pro-survival
mechanism. It’s worth mentioning, however, that additional
mechanisms have been described to activate and translocate
YB-1 to the nucleus (8).
Into the cytoplasm, YB-1 is known to act as a positive trans-
lational regulator of SNAIL1, a potent epithelial to mesenchy-
mal transition inducer able to reduce cell-cell adhesion and
increase migratory properties of cancer cells (33). Accordingly,
we have observed that enforced expression of YB-1 in tumor
cells increases their motility and migration speed. Remarkably,
we have shown that Np63-enforced expression reduces the
activating binding of YB-1 to the SNAIL1 transcript and
restores a normal migratory behavior to YB-1-overexpressing
cells. However, depletion of endogenous Np63 in SCC cells
results in SNAIL1 up-regulation, E-cadherin repression, and
increased cell motility.
Finally, cytoplasmic YB-1 is known to bind to actin filaments
and causes actin fibers to bundle in vitro (39). It was also dem-
onstrated that YB-1 plays a relevant role in the organization of
the actin cytoskeleton by binding to F-actin and microtubules
(40, 41). In normal conditions, SCC011 cells are round in shape
and exhibit a more diffuse actin distribution, as determined by
phalloidin staining. Here, we show that Np63 depletion in
SCCcellspromotesmorphological changesandcauses aprofound
cytoskeleton reorganization. Np63-depleted cells had a polar-
izedmorphologywithmoreevident lamellipodiaand trailingedge.
They also exhibited mature stress fibers suggesting a pro-migra-
tory behavior. The alterations in cell morphology and motility of
Np63-depleted SCC cells closely resemble the process of epi-
thelial to mesenchymal transition (28). We can speculate that the
absence ofNp63 can promote F-actin polymerization by YB-1
thereby promoting the formation of stress fibers.
All together, our data indicate that Np63-YB-1 associa-
tion into the nucleus can act as a pro-proliferative/survival
mechanism, although the loss of p63 predisposes the acquisi-
tion ofmesenchymal characteristics at least in part by restoring
YB-1 cytoplasmic functions.Moreover, we suggest that the bal-
ance betweenNp63 and YB-1 protein levels could be critical
for the transition to a mesenchyme-like phenotype explaining,
at least in part, why Np63 depletion promotes cancer cell
invasion and spreading (35).
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